Quality of life in patients with systemic lupus erythematosus: positive associations with younger age, higher education, low disease activity, and corticosteroid and cyclophosphamide treatment—cross-sectional study in northwestern Poland
- 1Department of Internal Medicine, Rheumatology, Diabetology, Geriatrics and Clinical Immunology, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1, Szczecin, 71-252 Poland
Abstract
Systemic lupus erythematosus (SLE) - chronic autoimmune disease affecting health-related quality of life (QoL). To estimate the associations between QoL and age, disease activity, education level, and treatment in patients with SLE. We studied 200 SLE patients. Data collected: sex, age, disease duration, socioeconomic status, disease activity, and treatment. QoL was assessed using the Lupus Quality of Life Questionnaire (LupusQoL), 36-Item Short Form Health Survey (SF-36), and Health Assessment Questionnaire (HAQ). Younger patients reported better QoL (all p < 0.001). Disease duration correlated positively with pain (p = 0.002) and role limitations due to physical health (p = 0.03) in the SF-36. Low SLEDAI correlated positively with QoL in most of the domains assessed by the LupusQoL (all p < 0.05), despite physical health, pain and burden to others, and intimate relationships (all p > 0.05). The use of CS improved physical health (p = 0.01) and physical functioning (p = 0.03) in the LupusQoL and SF-36, respectively. Intravenous cyclophosphamide improved physical health (p = 0.01), oral cyclophosphamide improved intimate relationships (p = 0.003) in the LupusQoL. Secondary and higher education correlated positively with planning (p = 0.007 and p = 0.005, respectively) and intimate relationships (p = 0.0001 and p = 0.0002, respectively) in the LupusQoL and with role limitations due to emotional problems (p = 0.01 and p = 0.007, respectively) in the SF-36. QoL assessment in patients with SLE was positively associated with younger age, higher education, low disease activity, and treatment.
Related
- Associations between the Chinese physical education and health Curriculum model to the psychological stress of junior middle school students: The chain mediating role of psychological resilience and physical self-efficacy
- Associations between adverse childhood experiences, depression, and empathy among Thai medical students: implications for trauma-informed medical education.
- Education and Alzheimer Disease Genetic Risk in Associations of GLP-1 Receptor Agonists With Dementia Among Adults With Type 2 Diabetes
- Sex Differences in the Associations between Education, Neuropathology, and Cognition
- Visceral metastatic angiosarcoma treated effectively with oral cyclophosphamide combined with propranolol
BibTeX
@article{bobrowskasnarska2026quality,
title = {{Quality of life in patients with systemic lupus erythematosus: positive associations with younger age, higher education, low disease activity, and corticosteroid and cyclophosphamide treatment—cross-sectional study in northwestern Poland}},
author = {Danuta Bobrowska-Snarska and Weronika Snarska-Pękała and Zuzanna Jurkowska and Marek Brzosko and Hanna Przepiera-Będzak},
journal = {Rheumatology International},
year = {2026},
month = oct,
doi = {10.1007/s00296-026-06337-4},
url = {https://doi.org/10.1007/s00296-026-06337-4},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Quality of life in patients with systemic lupus erythematosus: positive associations with younger age, higher education, low disease activity, and corticosteroid and cyclophosphamide treatment—cross-sectional study in northwestern Poland
AU - Danuta Bobrowska-Snarska
AU - Weronika Snarska-Pękała
AU - Zuzanna Jurkowska
AU - Marek Brzosko
AU - Hanna Przepiera-Będzak
PY - 2026
DA - 2026/10/31
JO - Rheumatology International
DO - 10.1007/s00296-026-06337-4
UR - https://doi.org/10.1007/s00296-026-06337-4
AB - Systemic lupus erythematosus (SLE) - chronic autoimmune disease affecting health-related quality of life (QoL). To estimate the associations between QoL and age, disease activity, education level, and treatment in patients with SLE. We studied 200 SLE patients. Data collected: sex, age, disease duration, socioeconomic status, disease activity, and treatment. QoL was assessed using the Lupus Quality of Life Questionnaire (LupusQoL), 36-Item Short Form Health Survey (SF-36), and Health Assessment Questionnaire (HAQ). Younger patients reported better QoL (all p < 0.001). Disease duration correlated positively with pain (p = 0.002) and role limitations due to physical health (p = 0.03) in the SF-36. Low SLEDAI correlated positively with QoL in most of the domains assessed by the LupusQoL (all p < 0.05), despite physical health, pain and burden to others, and intimate relationships (all p > 0.05). The use of CS improved physical health (p = 0.01) and physical functioning (p = 0.03) in the LupusQoL and SF-36, respectively. Intravenous cyclophosphamide improved physical health (p = 0.01), oral cyclophosphamide improved intimate relationships (p = 0.003) in the LupusQoL. Secondary and higher education correlated positively with planning (p = 0.007 and p = 0.005, respectively) and intimate relationships (p = 0.0001 and p = 0.0002, respectively) in the LupusQoL and with role limitations due to emotional problems (p = 0.01 and p = 0.007, respectively) in the SF-36. QoL assessment in patients with SLE was positively associated with younger age, higher education, low disease activity, and treatment.
SN - 0172-8172
SN - 1437-160X
ER -